Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks2.jpg" NAME"Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges" ALT"Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges"September 7, 2017By Mark Terry, BioSpace…
Source: BioSpace